Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.7900 (-4.1%) ($6.7900 - $7.1200) on Thu. Jul. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.02% (three month average) | RSI | 26 | Latest Price | $6.7900(-4.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -0.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -5.7% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XBI(72%) ARKG(70%) ARKK(67%) IWO(66%) ACES(63%) | Factors Impacting CGEN price | CGEN will decline at least -2.01% in a week (0% probabilities). VIXM(-49%) VXX(-37%) UUP(-15%) TLT(-7%) IGOV(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.01% (StdDev 4.02%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-8.79(-229.46%) | Resistance Level | $7.59 | 5 Day Moving Average | $6.89(-1.45%) | 10 Day Moving Average | $7.1(-4.37%) | 20 Day Moving Average | $7.59(-10.54%) | To recent high | -25.2% | To recent low | 1% | Market Cap | $561m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |